Drug Utilization Review (DUR) | Medicaid Since 1993, section 1927 (g) of the Act has required each state to develop a DUR program targeted, in part, at reducing clinical abuse and misuse of outpatient prescription drugs covered under the State’s Medicaid Program Medicaid DUR is a structured, ongoing program that interprets patterns of drug use in Medicaid programs and includes prospective drug review, retrospective drug use review
DUR: Retrospective DUR - California Retrospective Drug Use Review (DUR) is the comprehensive evaluation of claims data after dispensing, to ensure appropriate medication decision-making and positive patient outcomes The Medi-Cal retrospective DUR program includes the ongoing periodic examination of Medi-Cal claims data and other records to identify patterns of fraud, abuse, gross overuse, and inappropriate or medically
Drug Utilization Review - AMCP. org Drug utilization review (DUR) is defined as an authorized, structured, ongoing review of prescribing, dispensing and use of medication DUR encompasses a drug review against predetermined criteria that results in changes to drug therapy when these criteria are not met
Drug Utilization Review (DUR) | Definitive Healthcare Drug Utilization Review (DUR) What is Drug Utilization Review (DUR)? Drug Utilization Review (DUR) is a process by which healthcare entities can ensure they are properly prescribing, dispensing, and making use of prescription medication
Drug Utilization Review - PubMed Drug Utilization Review (DUR) is an ongoing, systematic quality-improvement activity constructed to ensure the effective and appropriate use of medicines It can also be considered a formulary system management technique
DUR: Educational Outreach The Global Medi-Cal Drug Use Review (DUR) Board (the “Board”) provides ongoing educational outreach to health care providers and pharmacists on drug therapy, to improve the quality and cost-effectiveness of prescribing and dispensing practices for Medi-Cal beneficiaries The DUR educational outreach program includes the following components listed in the Code of Federal Regulations, Title
Microsoft Word - PRxN DUR 3-09. doc - Pequot Healthcare What are Drug Utilization Reviews (DUR) Drug Utilization Reviews (DUR), also referred to as Drug Utilization Evaluations (DUE) or Medication Utilization Evaluations (MUE), are defined as an authorized, structured, ongoing review of healthcare provider prescribing, pharmacist dispensing, and patient use of medication DURs involve a comprehensive review of patients' prescription and medication
State Drug Utilization Review Reporting | Medicaid The Centers for Medicare Medicaid Services (CMS) requires states to provide annual drug utilization review (DUR) reports on their: Nature and scope of the prospective and retrospective drug use review programs Summary of DUR interventions Cost savings generated from their DUR programs Program’s operations Adoption of innovative DUR practices Description of DUR board activities Medicaid
Drug Utilization Review: Enhancing Medication Safety and . . . - DoveMed Explore the significance of Drug Utilization Review (DUR) in promoting medication safety and optimization Learn about the objectives, methods, and the role of DUR in enhancing patient outcomes and minimizing medication risks
DUR: Prospective DUR - California DUR: Prospective DUR Prospective Drug Use Review (DUR) is performed electronically at the time a drug is dispensed to a patient This review is designed to identify potential problems such as drug-drug interactions, therapeutic duplication, inappropriate dosage, or duration of therapy When a pharmacist is alerted to a potential problem, he or she is expected to use professional judgment to